Effect of Multidrug-Resistant 1 (MDR1) and CYP3A4*1B Polymorphisms on Cyclosporine-Based Immunosuppressive Therapy in Renal Transplant Patients-Reference-Cited by-同舟云学术

Effect of Multidrug-Resistant 1 (MDR1) and CYP3A4*1B Polymorphisms on Cyclosporine-Based Immunosuppressive Therapy in Renal Transplant Patients

Published:2019-02-25 Issue: Volume:24 Page:108-114
ISSN:2329-0358
Container-title:Annals of Transplantation
language:en
Short-container-title:Ann Transplant

Author:

Kotowski Maciej J.¹,Bogacz Anna²,Bartkowiak-Wieczorek Joanna³,Tejchman Karol⁴,Dziewanowski Krzysztof⁵,Ostrowski Marek⁴,Czerny Bogusław²,Grześkowiak Edmund³,Machaliński Bogusław¹,Sieńko Jerzy⁴

Affiliation:

1. Department of General Pathology, Pomeranian Medical University, Szczecin, Poland

2. Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants, Poznań, Poland

3. Laboratory of Experimental Pharmacogenetics, Department of Clinical Pharmacy and Biopharmacy, University of Medical Sciences, Poznań, Poland

4. Department of General Surgery and Transplantation, Pomeranian Medical University, Szczecin, Poland

5. Nephrology-Transplant Centre, Department of the Regional Public Hospital in Szczecin, Szczecin, Poland

Publisher

International Scientific Information, Inc.

Subject

Transplantation,General Medicine

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study Models of Drug–Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels;Molecules;2023-11-10

2. Pharmacogenomics of Old and New Immunosuppressive Drugs for Precision Medicine in Kidney Transplantation;Journal of Clinical Medicine;2023-07-03

3. Cannabis Pharmacogenomics: A Path to Personalized Medicine;Current Issues in Molecular Biology;2023-04-17

4. Influence of cyclosporine A trough level on acute graft versus host disease prophylaxis in pediatric allo- hematopoietic stem cell transplantation;2023-04-04

5. Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients;Biomedicines;2022-07-26